These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14698701)

  • 1. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants.
    Kühn KU; Quednow BB; Thiel M; Falkai P; Maier W; Elger CE
    Epilepsy Behav; 2003 Dec; 4(6):674-9. PubMed ID: 14698701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C; Baghai TC; Eser D; Zwanzger P; Jordan M; Buechs R; Rupprecht R
    Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.
    Sterr A; Padberg F; Amann B; Mergl R; Mulert C; Juckel G; Hegerl U; Pogarell O
    J Clin Psychiatry; 2006 Feb; 67(2):325-6. PubMed ID: 16566633
    [No Abstract]   [Full Text] [Related]  

  • 4. Reboxetine addition in patients with mirtazapine-resistant depression: a case series.
    López-Muñoz F; Rubio G; Alamo C; García-García P; Pardo A
    Clin Neuropharmacol; 2006; 29(4):192-6. PubMed ID: 16855420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy.
    Vermoesen K; Massie A; Smolders I; Clinckers R
    Epilepsia; 2012 May; 53(5):870-8. PubMed ID: 22429158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients.
    Brunnauer A; Laux G; David I; Fric M; Hermisson I; Möller HJ
    J Clin Psychiatry; 2008 Dec; 69(12):1880-6. PubMed ID: 19203476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.
    Muguruza C; Miranda-Azpiazu P; Díez-Alarcia R; Morentin B; González-Maeso J; Callado LF; Meana JJ
    Neuropharmacology; 2014 Nov; 86():311-8. PubMed ID: 25150943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reboxetine adjunct for partial or nonresponders to antidepressant treatment.
    Rubio G; San L; López-Muñoz F; Alamo C
    J Affect Disord; 2004 Jul; 81(1):67-72. PubMed ID: 15183602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.
    Langworth S; Bodlund O; Agren H
    J Clin Psychopharmacol; 2006 Apr; 26(2):121-7. PubMed ID: 16633139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restless legs syndrome as side effect of second generation antidepressants.
    Rottach KG; Schaner BM; Kirch MH; Zivotofsky AZ; Teufel LM; Gallwitz T; Messer T
    J Psychiatr Res; 2008 Nov; 43(1):70-5. PubMed ID: 18468624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study.
    Ng CG; Boks MP; Roes KC; Zainal NZ; Sulaiman AH; Tan SB; de Wit NJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):491-8. PubMed ID: 24503279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effects of antidepressants on negative symptoms in schizophrenia.
    Hinkelmann K; Yassouridis A; Kellner M; Jahn H; Wiedemann K; Raedler TJ
    J Clin Psychopharmacol; 2013 Oct; 33(5):686-90. PubMed ID: 23857309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal prolactin values correlate with response to reboxetine treatment in major depression, but not with response to citalopram.
    Moeller O; Hetzel G; Michael N; Rothermundt M; Arolt V; Erfurth A
    Neuropsychobiology; 2005; 51(2):67-71. PubMed ID: 15741746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased platelet count after treatment with venlafaxine or mirtazapine in depressed patients.
    Gronau W; Paslakis G; Lederbogen F; Weber-Hamann B; Gilles M; Schilling C; Deuschle M
    Pharmacopsychiatry; 2015 Jan; 48(1):37-9. PubMed ID: 25402815
    [No Abstract]   [Full Text] [Related]  

  • 16. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
    Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D
    J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.